Source: Medicines and Medical Devices Safety Authority (NZ) Revision Year: 2021 Publisher: Pfizer New Zealand Ltd, PO Box 3998, Auckland, NEW ZEALAND, Toll Free Number: 0800 736 363
SOLU-MEDROL 1 g powder for injection.
SOLU-MEDROL 2 g powder for injection*.
SOLU-MEDROL ACT-O-VIAL 40 mg/mL powder for injection.
SOLU-MEDROL ACT-O-VIAL 125 mg/2 mL powder for injection.
SOLU-MEDROL ACT-O-VIAL 500 mg/4 mL injection with diluent.
* Not available.
| Pharmaceutical Form |
|---|
|
SOLU-MEDROL:
SOLU-MEDROL ACT-O-VIAL:
|
Each vial with active constituent contains methylprednisolone sodium succinate equivalent to methylprednisolone 1 g.
Excipients with known effect: Each vial of diluent contains benzyl alcohol 140.4 mg as preservative.
When mixed as directed, each 16 mL contains methylprednisolone sodium succinate equivalent to methylprednisolone 1 g.
Each vial with active constituent contains methylprednisolone sodium succinate equivalent to methylprednisolone 2 g.
Excipients with known effect: Each vial of diluent contains benzyl alcohol 280.8 mg as preservative.
When mixed as directed, each 31.2 mL contains methylprednisolone sodium succinate equivalent to methylprednisolone 2 g.
The vial compartment with the active constituent contains methylprednisolone sodium succinate equivalent to methylprednisolone 40 mg.
When mixed, each mL contains methylprednisolone sodium succinate equivalent to 40 mg methylprednisolone.
The vial compartment with the active constituent contains methylprednisolone sodium succinate equivalent to methylprednisolone 125 mg.
When mixed, each 2 mL contains methylprednisolone sodium succinate equivalent to 125 mg methylprednisolone.
The vial compartment with the active constituent contains methylprednisolone sodium succinate equivalent to methylprednisolone 575 mg.
When mixed each 4 mL contains methylprednisolone sodium succinate equivalent to 500 mg methylprednisolone.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Methylprednisolone |
Methylprednisolone is a synthetic glucocorticoid and a methyl derivative of prednisolone. Methylprednisolone is a potent anti-inflammatory agent with the capacity to profoundly inhibit the immune system. |
| List of Excipients |
|---|
SOLU-MEDROL ACT-O-VIAL 40 mg/mL powder for injectionPowder for injection compartment:
Diluent compartment:
SOLU-MEDROL ACT-O-VIAL 125 mg/2 mL powder for injectionPowder for injection compartment:
Diluent compartment:
SOLU-MEDROL ACT-O-VIAL 500 mg/4 mLPowder for injection compartment:
Diluent compartment:
SOLU-MEDROL 1 g powder for injectionPowder for injection vial:
Diluent vial:
SOLU-MEDROL 2 g powder for injectionPowder for injection vial:
Diluent vial:
|
SOLU-MEDROL is available in the following pack sizes:
Not all presentations may be marketed.
SOLU-MEDROL is available in preservative and preservative-free formulations.
Pfizer New Zealand Ltd, PO Box 3998, Auckland, NEW ZEALAND, Toll Free Number: 0800 736 363
SOLU-MEDROL ACT-O-VIAL 40 mg/mL powder for injection: 26 July 1973
SOLU-MEDROL ACT-O-VIAL 125 mg/2 mL powder for injection: 21 January 1972
SOLU-MEDROL ACT-O-VIAL 500 mg/4 mL injection with diluent: 16 September 1999
SOLU-MEDROL 1 g powder for injection: 21 January 1972
SOLU-MEDROL 2 g powder for injection: 21 January 1972
| Drug | Countries | |
|---|---|---|
| SOLU-MEDROL | Austria, Australia, Brazil, Canada, Ecuador, Estonia, Finland, France, Hong Kong, Croatia, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
